Methods of treating fibrosis
AssigneePharmacyclics, Inc.
InventorsToni Jauset González, Daniel Massó-Vallés, Laura Soucek
Life of this patent
Estimating the term…
Abstract
Disclosed are methods of treating fibrosis in a patient, comprising administering to a patient in need thereof a therapeutically effective amount of an ACK inhibitor (e.g., a BTK inhibitor, such as for example an irreversible BTK inhibitor, such as for example, ibrutinib).
Claims5
A method of treating fibrosis, wherein the fibrosis is not associated with graft versus host disease (GVHD), comprising administering to a patient having fibrosis, wherein the fibrosis is not associated with GVHD, a therapeutically effective amount of a compound, which is 1-(R)-(3-(4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)prop-2-en-1-one (ibrutinib), of the structure:
- thereby treating the fibrosis.
Dependencies are inferred from the claim text.